Se-Jin Park
Finanzdirektor/CFO bei LIGACHEM BIOSCIENCES INC.
Vermögen: 9 Mio $ am 30.04.2024
Profil
Se-Jin Park is currently the Director at LegoChem Pharma, Inc. He is also a Non-Executive Director at BASKHANBIOPharma, Inc. and the Chief Operating & Financial Officer at LigaChem Biosciences, Inc. Previously, he worked as a Team Leader-Visual Materials at LG Chem Ltd.
from 2003 to 2006.
Dr. Park completed his undergraduate degree at Korea University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2024 | 181 528 ( 0,50% ) | 9 Mio $ | 30.04.2024 |
Aktive Positionen von Se-Jin Park
| Unternehmen | Position | Beginn |
|---|---|---|
| LIGACHEM BIOSCIENCES INC. | Finanzdirektor/CFO | 15.09.2011 |
| BASKHANBIO PHARMA INC. | Direktor/Vorstandsmitglied | 01.01.2016 |
LegoChem Pharma, Inc.
 LegoChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology LegoChem Pharma, Inc. manufactures pharmaceutical products. Its products include generic and prescription drugs, ophthalmic solvents, and ophthalmic surgical supplies. The company was founded in 1968 and is headquartered in Seoul, South Korea. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Se-Jin Park
| Unternehmen | Position | Ende |
|---|---|---|
| LG CHEM, LTD. | Corporate Officer/Principal | 01.06.2006 |
Ausbildung von Se-Jin Park
| Korea University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LIGACHEM BIOSCIENCES INC. | Health Technology |
| LG CHEM, LTD. | Process Industries |
| BASKHANBIO PHARMA INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LegoChem Pharma, Inc.
LegoChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology LegoChem Pharma, Inc. manufactures pharmaceutical products. Its products include generic and prescription drugs, ophthalmic solvents, and ophthalmic surgical supplies. The company was founded in 1968 and is headquartered in Seoul, South Korea. | Health Technology |
